HCA Healthcare, Inc. $HCA Stock Holdings Boosted by OLD National Bancorp IN

OLD National Bancorp IN increased its position in HCA Healthcare, Inc. (NYSE:HCA) by 70.7% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,791 shares of the company’s stock after acquiring an additional 742 shares during the period. OLD National Bancorp IN’s holdings in HCA Healthcare were worth $686,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $1,021,000. RFG Advisory LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $204,000. Sivia Capital Partners LLC acquired a new stake in HCA Healthcare during the 1st quarter worth about $206,000. Wedmont Private Capital increased its position in shares of HCA Healthcare by 20.2% in the first quarter. Wedmont Private Capital now owns 3,332 shares of the company’s stock worth $1,111,000 after acquiring an additional 559 shares in the last quarter. Finally, UMB Bank n.a. lifted its position in shares of HCA Healthcare by 19.1% in the 1st quarter. UMB Bank n.a. now owns 1,588 shares of the company’s stock valued at $549,000 after acquiring an additional 255 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent analyst reports. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Morgan Stanley decreased their price objective on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Finally, Barclays upped their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research note on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $407.75.

HCA Healthcare Trading Up 1.0%

HCA Healthcare stock opened at $433.83 on Tuesday. The company has a market capitalization of $101.51 billion, a P/E ratio of 18.24, a P/E/G ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $435.03. The firm’s fifty day simple moving average is $399.40 and its 200-day simple moving average is $373.65.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company earned $5.50 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.